Abstract
BackgroundLUNAR, a randomized controlled trial, investigated the addition of rituximab (RTX) to standard of care for the treatment of lupus nephritis (LN). While this study did not meet its primary...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have